Science. Simplicity. Partnership.

 

Roche granted FDA Breakthrough Device Designation for pTau217 blood test to support earlier Alzheimer's disease diagnosis
Alzheimer's Disease

Elecsys® pTau217 blood test receives FDA Breakthrough Device Designation

Test development is a Roche and Lilly collaboration to support earlier Alzheimer’s diagnosis.

Latest news

 

Forecasting the future of cancer diagnostics
Pathology
Forecasting the future of cancer diagnostics

One of our experts answers questions about innovations in tissue and digital pathology.

Learn more

Roche Diagnostics Lab Week 2024
Lab Week
Roche Diagnostics celebrates Lab Week

In a world where you can be anything, be a laboratory professional.

Learn more

Tucson Symposium
Oncology
Tucson Symposium

Thought leaders and cancer experts drive advancements in pathology and oncology to improve outcomes and shape the future.

Register now

Related links

Products

Learn more about our portfolio of lab instruments, systems, assays and more  

Begin exploring

Documents

More than 800,000 documents available on demand — always up-to-date with 24/7 access

Log in to eLabDoc

Education

Empowering learning — e-learning content, PACE/CEU courses, and more

Start training